AnaptysBio Inc. (ANAB)
NASDAQ: ANAB
· Real-Time Price · USD
21.08
1.27 (6.41%)
At close: Sep 18, 2025, 3:59 PM
20.95
-0.62%
After-hours: Sep 18, 2025, 05:59 PM EDT
6.41% (1D)
| Bid | 20.09 |
| Market Cap | 590.18M |
| Revenue (ttm) | 123.16M |
| Net Income (ttm) | -132.59M |
| EPS (ttm) | -4.39 |
| PE Ratio (ttm) | -4.8 |
| Forward PE | -4.1 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 21.5 |
| Volume | 305,494 |
| Avg. Volume (20D) | 505,769 |
| Open | 19.82 |
| Previous Close | 19.81 |
| Day's Range | 19.66 - 21.23 |
| 52-Week Range | 12.21 - 39.50 |
| Beta | -0.18 |
| Ex-Dividend Date | n/a |
About ANAB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANAB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANAB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAnaptysBio Inc. is scheduled to release its earnings on
Nov 4, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+7.59%
AnaptysBio shares are trading higher after the com...
Unlock content with
Pro Subscription
5 months ago
+9.54%
AnaptysBio shares are trading higher after the company announced a $75 million share buyback program.
1 month ago · fool.com
AnaptysBio (ANAB) Q2 Revenue Jumps 103%AnaptysBio (ANAB) Q2 Revenue Jumps 103%
